Diopsys, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Diopsys, Inc. - overview
Established
1998
Location
-, NJ, US
Primary Industry
Medical Devices & Equipment
About
Based in New Jersey, US, and founded in 1998, Diopsys, Inc. operates as a provider of modern visual electrophysiology medical devices. As of 2021, Joe Fontanetta serves as the CEO of the company. In March 2022, LumiThera, Inc.
, a portfolio company of Celeste Management, Keiretsu Forum, National Eye Institute, Nikon Corporation, RPR Ventures, and WaterStone Capital, acquired Diopsys, Inc. The company offers visual electrophysiological medical equipment that enables eye doctors to diagnose visual and neuro visual diseases by analyzing the complete visual pathway. Its vision testing technology includes visual evoked potential (VEP) and electroretinography (ERG). The Diopsys NOVA, Diopsys ARGOS, and Diopsys RETINA PLUS series of ERG and VEP vision monitoring products, as well as the Enfant vision monitoring system, Pediatric VEP, are all powered by this technology.
Current Investors
Nikon Corporation, LumiThera, Inc.
Primary Industry
Medical Devices & Equipment
Sub Industries
Optometrists & Opticians Products and Services, Diagnostic Equipment, Monitoring Equipment
Website
www.diopsys.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Diopsys, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.